Literature DB >> 1577971

Methods for detecting lupus anticoagulants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosus.

D Ferro1, M Saliola, C Quintarelli, G Valesini, S Basili, A M Grandilli, M S Bonavita, F Violi.   

Abstract

AIMS: To examine the sensitivity and specificity to past thrombotic events of four different coagulation tests, which screen for lupus anticoagulant (LA), and of anticardiolipin antibodies in patients with systemic lupus erythematosus.
METHODS: Fifty three consecutive patients with systemic lupus erythematosus were studied of whom three males and 21 females, aged 21-60 years, had a history of venous and arterial thrombosis, or miscarriage, or both. Activated partial thromboplastin time (aPTT), dilute Russell's viper venom time (dRVVT), kaolin clotting time (KCT), dilute aPTT and the circulating titre of anticardiolipin antibodies were investigated in the two groups of patients and in 20 healthy control subjects.
RESULTS: The prolonged dilute aPTT was more sensitive to thromboses or miscarriages, or both than dRVVT (p less than 0.05), KCT (p less than 0.01), and aPTT (p less than 0.001). No significant differences in specificity were found among aPTT (100%), dRVVT (93%), KCT (93%) and dilute aPTT (86.2%); but aPTT and dRVVT were significantly more specific (p less than 0.01, p less than 0.05, respectively) than anticardiolipin antibodies.
CONCLUSIONS: The study shows a strong association between lupus anticoagulant and thrombosis when a very sensitive test such as the dilute aPTT is used. The combination of this assay with a very specific test such as dRVVT might enable patients with SLE at high risk of thrombosis to be identified.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1577971      PMCID: PMC495275          DOI: 10.1136/jcp.45.4.332

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  62 in total

1.  The striking association between lupus anticoagulant and fetal loss in systemic lupus erythematosus patients.

Authors:  R H Derksen; B N Bouma; L Kater
Journal:  Arthritis Rheum       Date:  1986-05

2.  The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level.

Authors:  M Petri; M Rheinschmidt; Q Whiting-O'Keefe; D Hellmann; L Corash
Journal:  Ann Intern Med       Date:  1987-04       Impact factor: 25.391

3.  Lupus anticoagulant and thrombosis in systemic lupus erythematosus.

Authors:  P Jungers; F Liote; M D Dautzenberg; C Gazengel; M Dougados; F Tron; J F Bach
Journal:  Lancet       Date:  1984-03-10       Impact factor: 79.321

4.  Studies on the relationship between 'antiphospholipid' antibodies and the lupus anticoagulant.

Authors:  T Exner; J McRea
Journal:  Blood Coagul Fibrinolysis       Date:  1990 Mar-Apr       Impact factor: 1.276

5.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

6.  Fetal survival after prednisone suppression of maternal lupus-anticoagulant.

Authors:  W F Lubbe; W S Butler; S J Palmer; G C Liggins
Journal:  Lancet       Date:  1983-06-18       Impact factor: 79.321

7.  Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases.

Authors:  D A Gastineau; F J Kazmier; W L Nichols; E J Bowie
Journal:  Am J Hematol       Date:  1985-07       Impact factor: 10.047

8.  The laboratory diagnosis of lupus anticoagulants.

Authors:  J Lazarchick; J Kizer
Journal:  Arch Pathol Lab Med       Date:  1989-02       Impact factor: 5.534

9.  The dilute phospholipid APTT: a sensitive assay for verification of lupus anticoagulants.

Authors:  B M Alving; P E Baldwin; R L Richards; B J Jackson
Journal:  Thromb Haemost       Date:  1985-10-30       Impact factor: 5.249

Review 10.  Lupus anticoagulant: revival of an old phenomenon.

Authors:  R H Derksen; L Kater
Journal:  Clin Exp Rheumatol       Date:  1985 Oct-Dec       Impact factor: 4.473

View more
  2 in total

1.  Presence of lupus anticoagulant in an asymptomatic Nigerian.

Authors:  Edeghonghon E Olayemi; Godwin N Bazuaye
Journal:  Afr Health Sci       Date:  2007-09       Impact factor: 0.927

2.  Lupus anticoagulants and anticardiolipin antibodies in Indian women with spontaneous, recurrent fetal loss.

Authors:  Akanksha Rawat; Meera Sikka; Usha Rusia; Kiran Guleria
Journal:  Indian J Hematol Blood Transfus       Date:  2014-07-08       Impact factor: 0.900

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.